Neue Ansätze zur Regeneration der insulinproduzierenden β-Zelle

Historically, drug discovery was mainly focused on the development of so-called insulin sensitizers to address insulin resistance in type 2 diabetes. However, after scientists identified the failure and/or loss of pancreatic β‑cells as a cause for diabetes, research into the protection and regeneration of β‑cells gained increasing attention. Regenerative approaches under development include protecting β‑cells from stress-mediated cell death, augmenting β‑cell number, and improving their function. A number of molecular targets and drug candidates have been identified and validated in animal models. Novel, targeted therapies with curative potential are expected to enter the clinical phase in the medium term.